Pyruvate kinase type M2: a key regulator within the tumour metabolome and a tool for metabolic profiling of tumours
- PMID: 18811055
- DOI: 10.1007/2789_2008_091
Pyruvate kinase type M2: a key regulator within the tumour metabolome and a tool for metabolic profiling of tumours
Abstract
Normal proliferating cells and tumour cells in particular express the pyruvate kinase isoenzyme type M2 (M2-PK, PKM2). The quaternary structure of M2-PK determines whether the glucose carbons are degraded to pyruvate and lactate with production of energy (tetrameric form) or channelled into synthetic processes, debranching from glycolytic intermediates such as nucleic acid, amino acid and phospholipid synthesis. The tetramer:dimer ratio of M2-PK is regulated by metabolic intermediates, such as fructose 1,6-P2 and direct interaction with different oncoproteins, such as pp60v-src kinase, HPV-16 E7 and A-Raf. The metabolic function of the interaction between M2-PK and the HERC1 oncoprotein remains unknown. Thus, M2-PK is a meeting point for different oncogenes and metabolism. In tumour cells, the dimeric form of M2-PK is predominant and has therefore been termed Tumour M2-PK. Tumour M2-PK is released from tumours into the blood and from gastrointestinal tumours also into the stool of tumour patients. The quantification of Tumour M2-PK in EDTA plasma and stool is a tool for early detection of tumours and therapy control.
Similar articles
-
Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells.Int J Biochem Cell Biol. 2011 Jul;43(7):969-80. doi: 10.1016/j.biocel.2010.02.005. Epub 2010 Feb 13. Int J Biochem Cell Biol. 2011. PMID: 20156581 Review.
-
Pyruvate kinase type M2: a crossroad in the tumor metabolome.Br J Nutr. 2002 Jan;87 Suppl 1:S23-9. Br J Nutr. 2002. PMID: 11895152 Review.
-
Effects of the human papilloma virus HPV-16 E7 oncoprotein on glycolysis and glutaminolysis: role of pyruvate kinase type M2 and the glycolytic-enzyme complex.Biochem J. 2001 May 15;356(Pt 1):247-56. doi: 10.1042/0264-6021:3560247. Biochem J. 2001. PMID: 11336658 Free PMC article.
-
The tumor metabolome.Anticancer Res. 2003 Mar-Apr;23(2A):1149-54. Anticancer Res. 2003. PMID: 12820363
-
Pyruvate kinase type M2 and its role in tumor growth and spreading.Semin Cancer Biol. 2005 Aug;15(4):300-8. doi: 10.1016/j.semcancer.2005.04.009. Semin Cancer Biol. 2005. PMID: 15908230 Review.
Cited by
-
STAT6 promotes bi-directional modulation of PKM2 in liver and adipose inflammatory cells in rosiglitazone-treated mice.Sci Rep. 2013;3:2350. doi: 10.1038/srep02350. Sci Rep. 2013. PMID: 23917405 Free PMC article.
-
PKM2 phosphorylates MLC2 and regulates cytokinesis of tumour cells.Nat Commun. 2014 Nov 21;5:5566. doi: 10.1038/ncomms6566. Nat Commun. 2014. PMID: 25412762 Free PMC article.
-
Single-cell and spatial transcriptomics reveal a high glycolysis B cell and tumor-associated macrophages cluster correlated with poor prognosis and exhausted immune microenvironment in diffuse large B-cell lymphoma.Biomark Res. 2024 Jun 5;12(1):58. doi: 10.1186/s40364-024-00605-w. Biomark Res. 2024. PMID: 38840205 Free PMC article.
-
Detection of Nail Oncometabolite SAICAR in Oral Cancer Patients and Its Molecular Interactions with PKM2 Enzyme.Int J Environ Res Public Health. 2021 Oct 26;18(21):11225. doi: 10.3390/ijerph182111225. Int J Environ Res Public Health. 2021. PMID: 34769743 Free PMC article.
-
Pyruvate Kinase M2 and Cancer: The Role of PKM2 in Promoting Tumorigenesis.Front Oncol. 2020 Mar 2;10:159. doi: 10.3389/fonc.2020.00159. eCollection 2020. Front Oncol. 2020. PMID: 32195169 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous